The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
PIKA COVID-19 vaccine is currently in Phase 3, multi-country, multi-center clinical trial conducted at Southeast Asian and Middle East countries.
India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Subscribe To Our Newsletter & Stay Updated
